Nigerians get alternatives to capsules, injections for pains

A leading global healthcare company, Hisamitsu Pharmaceutical Co. Inc., has introduced Salonpas products, which are alternatives to injections and capsules, in Nigeria.

During the launch in Lagos State, the Executive Officer and Head of the International Division of Hisamitsu Pharmaceutical Co. Inc., Mr. Taro Hiramatsu, said the products were introduced in Nigeria after 90 years of existence in other countries, including Asia, the United Kingdom, and the United States.

The launch, which was attended by dignitaries in Nigeria’s health sector, also saw Mr Taro Hiramatsu assuring Nigerians of the company’s dedication to improving the lives of individuals suffering from various types of pain.

According to him, the Nigerian authorities have certified Salonpas Pain Relieving Patch 10’s, Salonpas Pain Relief Patch 5’s and Salonpas Jet Spray, for sale and distribution in the country.

He also affirmed that Salonpas would make a positive difference in the lives of Nigerians dealing with back, leg, knee, shoulder or knee pain daily as it did successfully in other parts of the world.

He said, “We are thrilled to bring Salonpas to Nigeria and to introduce our range of pain relief products to the Nigerian market. We understand that Nigerians are active and hardworking, and pain can slow them down. Salonpas provides quick and reliable pain relief solutions.”

Also, the President & Managing Director of Hisamitsu UK Limited, Mr Hiroki Nunotani, explained that Salonpas is an OTC topical analgesic solution tailored for athletes, professionals, the elderly or anyone seeking relief from daily pain and stiffness.

He noted, “By launching in Nigeria, Salonpas aims to make its products more accessible to a broader audience, enabling more people to experience the benefits of its cutting-edge pain relief technology. Our products are well-known for their advanced formulas that combine traditional medicinal approaches with modern technology, delivering targeted relief for muscle aches, joint pain, backaches, strains, and sprains. Whether it’s the Salonpas Pain Relief Patch or the Salonpas Jet Spray, each product is designed to address specific pain issues and enhance overall well-being.”

The President of the Pharmaceutical Society of Nigeria, Prof Cyril Usifoh, commended Salonpas’ launch in the Nigerian market.

Speaking at the launch he said, “With the launch in Nigeria, individuals will have access to another trusted brand that has been a household name in many countries for over 90 years. This will strengthen healthcare delivery in Nigeria.”

Co-founder and Chief Executive Officer of DrugStoc, Dr Chibuzo Opara, noted that the company would ensure quality-oriented distribution in Nigeria, assuring pharmacists and healthcare providers that the products have been approved by regulatory authorities.

“With our experience in the Nigerian market, patients, and healthcare providers can be assured of getting the products (Salonpas Pain Relieving Patch 10’s, Salonpas Pain Relief Patch 5’s and Salonpas Jet Spray) easily when needed in the country through us,” he said.

Among other health professionals present at the launch were the Past President of the Pharmaceutical Society of Nigeria and Chief Executive Officer of Pharmaplus, Ahmed Yakassai; the Chief Executive Officer of Victory Drugs, Folashade Lawal; the Chief Operating Officer of Bydow Pharmacy, Bolanle Adekunle; Pharmacist Grace Ikani; Chairman Pharmaceutical Society of Nigeria, Lagos State Chapter, Gbolagade Iyiola; Co-Founders of Drug Stoc Limited, Mr Adham Yehia and Dr Chibuzor Opara; and National Chairman Association of Community Pharmacists Nigeria, Adewale Oladigbolu.